Related references
Note: Only part of the references are listed.Pseudomonas aeruginosa sabotages the generation of host proresolving lipid mediators
Becca A. Flitter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Aspirin-triggered resolvin D1 is produced during self-resolving gram-negative bacterial pneumonia and regulates host immune responses for the resolution of lung inflammation
R. E. Abdulnour et al.
MUCOSAL IMMUNOLOGY (2016)
Resolvin D2 decreases TLR4 expression to mediate resolution in human monocytes
Amanda Croasdell et al.
FASEB JOURNAL (2016)
Resolvin D1 Dampens Pulmonary Inflammation and Promotes Clearance of Nontypeable Haemophilus influenzae
Amanda Croasdell et al.
JOURNAL OF IMMUNOLOGY (2016)
Resolvin D1 Polarizes Primary Human Macrophages toward a Proresolution Phenotype through GPR32
Mattia Schmid et al.
JOURNAL OF IMMUNOLOGY (2016)
Resolution of inflammation: a new therapeutic frontier
James N. Fullerton et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections
Craig Winstanley et al.
TRENDS IN MICROBIOLOGY (2016)
Tracking the immunopathological response to Pseudomonas aeruginosa during respiratory infections
Cristina Cigana et al.
SCIENTIFIC REPORTS (2016)
IL-17A impairs host tolerance during airway chronic infection by Pseudomonas aeruginosa
Nicola Ivan Lore et al.
SCIENTIFIC REPORTS (2016)
Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis
Lucy V. Norling et al.
JCI INSIGHT (2016)
Specialized pro-resolving mediators: endogenous regulators of infection and inflammation
Maria C. Basil et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Identification of resolvin D2 receptor mediating resolution of infections and organ protection
Nan Chiang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy
Youn Jeong Kim et al.
BMC INFECTIOUS DISEASES (2014)
Combination Therapy of 15-Epi-Lipoxin A 4 With Antibiotics Protects Mice From Escherichia coli-Induced Sepsis*
Tomomi Ueda et al.
CRITICAL CARE MEDICINE (2014)
Resolvin D1 improves survival in experimental sepsis through reducing bacterial load and preventing excessive activation of inflammatory response
F. Chen et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2014)
Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages
Antonio Recchiuti et al.
FASEB JOURNAL (2014)
A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis
M. W. Konstan et al.
JOURNAL OF CYSTIC FIBROSIS (2014)
Pro-resolving lipid mediators are leads for resolution physiology
Charles N. Serhan
NATURE (2014)
Characterisation of Leukocytes in a Human Skin Blister Model of Acute Inflammation and Resolution
William Jenner et al.
PLOS ONE (2014)
Plasma Metabolomics in Human Pulmonary Tuberculosis Disease: A Pilot Study
Jennifer K. Frediani et al.
PLOS ONE (2014)
Efficacy and safety of 15(R/S)-methyl-lipoxin A4 in topical treatment of infantile eczema
S-H Wu et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Resolution of inflammation: an integrated view
Almudena Ortega-Gomez et al.
EMBO MOLECULAR MEDICINE (2013)
Resolvin D1 Receptor Stereoselectivity and Regulation of Inflammation and Proresolving MicroRNAs
Sriram Krishnamoorthy et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Resolvin D1 Limits Polymorphonuclear Leukocyte Recruitment to Inflammatory Loci Receptor-Dependent Actions
Lucy V. Norling et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Resolvin D1 and Aspirin-Triggered Resolvin D1 Promote Resolution of Allergic Airways Responses
Alexandre P. Rogerio et al.
JOURNAL OF IMMUNOLOGY (2012)
Infection regulates pro-resolving mediators that lower antibiotic requirements
Nan Chiang et al.
NATURE (2012)
An Official American Thoracic Society Workshop Report: Features and Measurements of Experimental Acute Lung Injury in Animals
Gustavo Matute-Bello et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2011)
MicroRNAs and the resolution phase of inflammation in macrophages
Muhammad M. Alam et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits
Antonio Recchiuti et al.
FASEB JOURNAL (2011)
17(R)-Resolvin D1 differentially regulates TLR4-mediated responses of primary human macrophages to purified LPS and live E. coli
Christine D. Palmer et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
Resolvin D1 protects mice from LPS-induced acute lung injury
Bin Wang et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2011)
Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21
Frederick J. Sheedy et al.
NATURE IMMUNOLOGY (2010)
Resolvin D1 binds human phagocytes with evidence for proresolving receptors
Sriram Krishnamoorthy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Pseudomonas aeruginosa Microevolution during Cystic Fibrosis Lung Infection Establishes Clones with Adapted Virulence
Alessandra Bragonzi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Inescapable Need for Neutrophils as Mediators of Cellular Innate Immunity to Acute Pseudomonas aeruginosa Pneumonia
Andrew Y. Koh et al.
INFECTION AND IMMUNITY (2009)
Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions
Charles N. Serhan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis
Matthew Spite et al.
NATURE (2009)
Resolvin E1 regulates interleukin 23, interferon-γ and lipoxin A4 to promote the resolution of allergic airway inflammation
Oliver Haworth et al.
NATURE IMMUNOLOGY (2008)
Resolvin D1 and its aspirin-triggered 17R epimer -: Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation
Yee-Ping Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
MicroRNA-155 is induced during the macrophage inflammatory response
Ryan M. O'Connell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness
Bruce D. Levy et al.
JOURNAL OF IMMUNOLOGY (2007)
Sequence diversity of the mucABD locus in Pseudomonas aeruginosa isolates from patients with cystic fibrosis
Alessandra Bragonzi et al.
MICROBIOLOGY-SGM (2006)
Regulation of pulmonary Pseudomonas aeruginosa infection by the transcriptional repressor Gfi1
Heike Grassme et al.
CELLULAR MICROBIOLOGY (2006)
Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model
A Bragonzi et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Molecular circuits of resolution: Formation and actions of resolvins and protectins
GL Bannenberg et al.
JOURNAL OF IMMUNOLOGY (2005)
Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung
CG Lee et al.
NATURE MEDICINE (2004)
Resolvins: A family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals
CN Serhan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Novel lipid mediator regulators of endothelial cell proliferation and migration:: Aspirin-triggered-15R-lipoxin A4 and lipoxin A4
IM Fierro et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Lipid mediator class switching during acute inflammation: signals in resolution
BD Levy et al.
NATURE IMMUNOLOGY (2001)
Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing
CN Serhan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
